Photo of: R. Valicenti

R. K. Valicenti

View Title...

Thomas Jefferson University
Philadelphia, Pennsylvania
R.'s profile was created using:
Sort By:

1 of 1 online source for R. Valicenti

  • View Online Source
    ASCO - Advances in Prostate Cancer Treatment Strategies - [Cached Version]
    Published on: 2/25/2006    Last Visited: 5/1/2006  

    Lead Author: Richard Valicenti, MD
    ...
    "Our findings indicate there may be an advantage to offering radiation therapy earlier after surgery to some patients found to have locally advanced prostate cancer, particularly if certain features of the tumor indicate the cancer may be aggressive," said Richard Valicenti, MD, Associate Professor and Clinical Director of Radiation Oncology at Thomas Jefferson University in Philadelphia and lead author of the study.

    The prevailing opinion has been that waiting to give a patient radiation therapy until his PSA level begins to rise following surgery (salvage therapy) avoids treating those patients whose cancer will never recur and is just as effective for controlling cancer progression as starting radiation therapy shortly after surgery (adjuvant therapy).
    ...
    R. K. Valicenti, A. L. Hanlon, T. M. Pisansky, H. M. Sandler, D. A. Kuban, C. Catton, J. M. Michalski, M. J. Zelefsky, P. A. Kupelian, A. Pollack, T. L. DeWeese

Wrong Person?

Related searches
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM13